Core Viewpoint - James Hardie Building Products Inc. reaffirms its commitment to affordable housing and climate-resilient communities through sponsorship of Habitat for Humanity's initiatives, particularly the 2025 Jimmy & Rosalynn Carter Work Project [1][4][5] Group 1: Commitment to Affordable Housing - James Hardie is sponsoring Habitat for Humanity's 2025 Jimmy & Rosalynn Carter Work Project in Austin, Texas, focusing on building safe and affordable homes [4] - The company emphasizes its purpose of "Building a Better Future for All" by creating lasting impacts in neighborhoods across the country [3][4] Group 2: Habitat Strong Initiative - The Habitat Strong initiative aims to develop climate-resilient housing that withstands extreme weather while remaining affordable and energy-efficient [5] - James Hardie's durable products, which are noncombustible and resilient against moisture and pests, play a crucial role in these housing projects [5][8] Group 3: Community Engagement and Fundraising - James Hardie engages its employees as volunteers in Habitat Strong projects, enhancing its impact on local communities [4] - The company also hosts the annual James Hardie Pro Football Hall of Fame Invitational, which raises funds for Habitat for Humanity, contributing to affordable housing initiatives [6]

NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into James Hardie Industries plc (NYSE: JHX) for potential violations of the federal securities laws. If you invested in James Hardie, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/james-hardie-industries-class-action-lawsuit. Why Is James Hardie being Investigated?James Hardie is a producer and marketer of high-performance fiber cement ...

Core Viewpoint - James Hardie Industries plc has appointed Samara Toole as Chief Marketing Officer to enhance its marketing strategy across its brand portfolio [1] Group 1: Appointment Details - Samara Toole will be part of the executive leadership team [1] - Toole will lead marketing strategy and execution for the James Hardie®, TimberTech®, and AZEK Exteriors® brands [1]

Core Viewpoint - James Hardie Industries plc is under investigation for potential violations of federal securities laws, following a significant decline in its stock price due to disappointing sales results attributed to temporary inventory loading rather than sustainable customer demand [1][4]. Company Overview - James Hardie is a producer and marketer of high-performance fiber cement and fiber gypsum building solutions, primarily used in external siding for the residential building industry in the United States and Canada [2]. Sales Performance - The company claimed that its "fast[]-growing customers" were a key aspect of its competitive positioning, asserting that its North American business results demonstrated inherent strength and momentum in its strategy [3]. - However, it appears that North American sales may have been artificially inflated due to temporary inventory loading by channel partners, rather than genuine customer demand [3]. Financial Results - On August 19, 2025, James Hardie reported a 12% decline in North American net sales for fiscal Q1 2026, attributing this to lower volumes as customers adjusted their inventory levels [4]. - The company indicated that significant inventory destocking among channel partners would continue to negatively impact sales for the upcoming quarters [4]. Stock Market Reaction - Following the earnings report, James Hardie's stock price plummeted by $9.79 per share, a decrease of over 34%, dropping from $28.43 to $18.64 on August 20, 2025 [4].

Core Insights - Bragar Eagel & Squire, P.C. is investigating potential claims against James Hardie Industries plc for possible violations of federal securities laws and unlawful business practices [1][2] Company Financial Performance - On August 19, 2025, James Hardie reported a 29% decline in first-quarter profit for the period ending June 30, 2025, and projected lower-than-expected earnings for fiscal 2026 due to high borrowing costs [5] - Following the announcement, James Hardie's American Depositary Receipt (ADR) price fell by $9.79, or 34.44%, closing at $18.64 per ADR on August 20, 2025 [5] Legal and Investor Relations - Investors who suffered losses from purchasing or acquiring James Hardie shares are encouraged to contact Bragar Eagel & Squire for discussions regarding their legal rights [1][2] - The law firm offers no-cost consultations for affected investors and is seeking information from long-term stockholders [2]

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud and unlawful business practices involving James Hardie Industries plc and its officers or directors [1] Financial Performance - On August 19, 2025, James Hardie reported a 29% decline in first-quarter profit for the period ending June 30, 2025, and projected lower-than-expected earnings for fiscal 2026 due to high borrowing costs [3] - Following the announcement, James Hardie's American Depositary Receipt (ADR) price dropped by $9.79, or 34.44%, closing at $18.64 per ADR on August 20, 2025 [3]

Core Viewpoint - James Hardie Industries plc is under investigation for potential violations of federal securities laws, with concerns regarding the sustainability of its North American sales growth [1][3]. Company Overview - James Hardie is a producer and marketer of high-performance fiber cement and fiber gypsum building solutions, primarily used in external siding for the residential building industry in the U.S. and Canada [2]. Sales Performance - The company previously claimed that its "fast[]-growing customers" were a key aspect of its competitive positioning and that its North American business results demonstrated inherent strength [3]. - However, it appears that North American sales may have been artificially inflated due to temporary inventory loading by channel partners rather than sustainable customer demand [3]. Recent Financial Results - On August 19, 2025, James Hardie reported a 12% decline in North American net sales for fiscal Q1 2026, attributing this to lower volumes as customers adjusted inventory levels [4]. - The company anticipates continued inventory destocking among channel partners will negatively impact sales for the upcoming quarters [4]. - Following the earnings report, James Hardie's stock price dropped by $9.79, or over 34%, from $28.43 to $18.64 per share [4].

Core Viewpoint - James Hardie Industries plc is under investigation for potential violations of federal securities laws, following a significant decline in its stock price due to misleading statements about its North American sales performance [1][4]. Company Overview - James Hardie is a producer and marketer of high-performance fiber cement and fiber gypsum building solutions, primarily used in external siding for the residential building industry in the United States and Canada [2]. Sales Performance and Misleading Statements - The company previously claimed that its "fast[]-growing customers" were a key aspect of its competitive positioning and that its North American business results demonstrated inherent strength [3]. - However, it appears that the North American sales growth was driven by temporary inventory loading by channel partners rather than sustainable customer demand [3]. Financial Results and Stock Impact - On August 19, 2025, James Hardie reported a 12% decline in North American net sales for fiscal Q1 2026, attributing this to lower volumes as customers adjusted inventory levels [4]. - Following this announcement, the stock price plummeted by $9.79 per share, a decrease of over 34%, from $28.43 to $18.64 [4].

Group 1: James Hardie Industries - James Hardie Industries is a building solutions company and the world's largest producer of fibre cement and gypsum products, operating across North America, Europe, Australia, and New Zealand with over 5,200 employees [1] - The share price of James Hardie Industries (ASX:JHX) has decreased by approximately 41.8% since the beginning of 2025 [1] - Currently, James Hardie Industries plc shares have a price-sales ratio of 2.77x, which is lower than its 5-year average of 4.14x, indicating that the shares are trading below historical averages despite revenue growth over the last three years [7] Group 2: CSL Limited - CSL is a global biotechnology company focused on creating and delivering life-saving medicines, with a mission to protect public health and improve the quality of life for individuals with life-threatening conditions [3] - The company operates through three main divisions: CSL Behring, which manufactures blood plasma products; CSL Seqirus, which develops flu-related products; and CSL Vifor, specializing in iron deficiency and nephrology [4] - CSL has established a strong reputation among Australian investors for reliability and consistent dividend payouts, making it a favored choice for those seeking exposure to the growing healthcare sector [5] - CSL is currently paying a trailing dividend yield of around 1.95%, which is higher than its 5-year average of 1.50%, indicating stability and the ability to provide income [8]

Core Viewpoint - James Hardie Industries plc is under investigation for potential violations of federal securities laws, following a significant decline in its stock price due to disappointing sales results attributed to temporary inventory loading rather than sustainable customer demand [1][4]. Company Overview - James Hardie is a producer and marketer of high-performance fiber cement and fiber gypsum building solutions, primarily used in external siding for the residential building industry in the United States and Canada [2]. Sales Performance - The company previously claimed that its "fast[]-growing customers" were a key aspect of its competitive positioning, asserting that its North American business results demonstrated inherent strength and momentum in its strategy [3]. - However, it was revealed that North American net sales declined by 12% in fiscal Q1 2026, driven by lower volumes as customers adjusted inventory levels, indicating that previous sales may have been artificially inflated [4]. Stock Market Reaction - Following the earnings call on August 19, 2025, where the sales decline was disclosed, James Hardie's stock price plummeted by $9.79 per share, a decrease of over 34%, from $28.43 to $18.64 [4].